Top Tech Companies (764)
Don't see your company?
Create a company profile
Tergus Pharma is an end-to-end service provider for topical pharmaceutical products supporting early phase research and formulation, drug development, testing, and both clinical and commercial manufacturing at our new 100,000 sq. ft. state-of-the-art facility in Durham, North Carolina. Tergus is the industry leader for topical/skin semi-solids and liquids as well as other non-skin semi-solids/liquids for vaginal, rectal and otic/ophthalmic routes of administration where we recognize the value of our stellar industry reputation for delivering quality results to clients. With industry-recognized leadership and expertise in method development, such as IVRT/IVPT for topical pharmaceuticals, Tergus also provides clients with peace of mind and helps them to de-risk their product development. Exclusively focused on topical development and manufacturing, Tergus brings the scientific expertise that helps our clients achieve the right balance of scientific knowhow, speed of results, and quality in product service, warranting our company motto, “Think Topicals, Think Tergus.
.jpg)
Your Partners in Medical Affairs - The Medical Affairs Company (TMAC) provides a full range of flexible and customizable medical affairs solutions to meet our Clients' needs. TMAC’s services include the provision of contract field-based medical teams, medical information, and medical affairs consulting, all designed to address company resource, timing and budget challenges. Field-based Medical Affairs Careers: We’ve set the industry standard in contract field-based medical affairs recruiting. TMAC’s internal specialized Talent Acquisition Team has a 20-year track record of success in building national field-based Medical Affairs and MSL Teams. They are adept at identifying and attracting the right individuals to fit the needs of each specific program and matching a candidate's talent to the skill set required for each position. Work alongside our clients, including many of the top ten pharma companies around the globe, as well as up and coming companies who are advancing cutting edge science and novel technology. Mesh your own science and business acumen as we improve the way medicine impacts lives. Whether you’re actively seeking a position or just keeping an open door to opportunities, we deliver the right people to the right companies, every time. TMAC’s Executive Leaders and management team have been actively involved in the outsourced medical affairs sector for over 20 years and have continued to further develop and evolve strategic solutions that meet the needs of today’s biopharmaceutical, diagnostic and medical device clients. TMAC realizes that not all programs are alike and customizes each program to the specific company’s culture, therapeutic area, product lifecycle stage and stakeholders needs. The Management Team of department leads, field medical Directors & Managers is made up of some of the best talent in the industry with unmatched experience working with programs of all sizes and specialties and in a wide range of therapeutic areas.
AIT Bioscience offers bioanalytical contract research services for preclinical and clinical trials.
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
TheraTarget is led by world-renown experts in polymer-drug chemistry.
AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at very small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) and generic peptide APIs under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes. Ambio is a drug development company with a rich and growing pipeline of proprietary drug development programs for bioequivalent and biosimilar versions of the world’s best-selling peptide drugs. Ambio Pharmaceuticals is the parent company of AmbioPharm, Inc. and Ambio, Inc.
Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well. Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes. Cygnus is an industry pioneer responsible for developing and commercializing the first generic assay kits for HCP detection. Its reputation for quality is recognized by the industry and global regulatory agencies. It continues to advance the science of bioprocess impurity detection with new breakthroughs, including its Antibody Affinity Extraction™ (AAE) technology and orthogonal methods of HCP analysis that integrate Mass Spectrometry, AAE and ELISA. To reduce the cost and risk associated with viral clearance studies, Cygnus also offers a unique approach that utilizes non-infectious mock virus particles through its MockV™ virus clearance kits. Cygnus’ proprietary technology, available through its off-the-shelf and custom analytics programs, sets the gold standard for enabling HCP and other bioprocess impurity antibody assays. Cygnus delivers best-in-class customer service and technical expertise, operational excellence and ISO-9001:2015 certified quality management systems. Founded by Ken Hoffman in 1997, Cygnus continues to support and advance technology in order to improve biotherapeutic safety and accelerate the movement of new therapeutics through the development and regulatory approval process. Located in Southport, North Carolina, Cygnus Technologies is online at www.cygnustechnologies.com.
Who We Are Triangle Insights Group is a strategy consulting firm providing guidance on the most critical business issues to leaders in life sciences organizations. The firm’s approach combines deep knowledge of the industry, across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking. Recommendations from Triangle Insights Group are original, relevant to the industry environment, and supported by rigorous analytics. Our Vision Our goal is ambitious: to redefine how you think about life sciences consultancies. To replace confusion with clarity. To deliver insights and strategies that foster confidence. Through every step of our customized approaches, you’ll benefit from the personal attention of an entire team of accomplished advisors —their collective vision, collaborative approach and total commitment. Our History Triangle Insights Group, established in April 2013, is an entrepreneurial company. The founding partners are experienced strategy consultants whose backgrounds include Campbell Alliance, Mercer, Boston Consulting Group, and Boston Healthcare. In 2022, the firm was acquired by TrialCard.
At QuartzBio, we help overcome the data chaos inherent in modern drug development. We serve clinical operations and translational research teams in oncology, autoimmune, CNS and other biomarker-rich therapeutic areas, whose progress hinges on navigating and connecting a complex data ecosystem. Our suite of fully connected, end-to-end SaaS solutions is engineered specifically to address the challenges of both sample data and biomarker data management -- providing a single, scalable data platform solution to the biotech and pharma sectors. We invite you to connect with our experienced, multidisciplinary, global team – we're industry leaders in biomarker data management, clinical operations, and translational informatics, with a focus on precision medicine. Our team members’ wide-ranging specialties include data management, biostatistics, immunology, and genomics. Send us a message, we’d love to chat
ICS, a business unit of AmerisourceBergen, partners with pharmaceutical manufacturers to deliver third-party logistics services that improve the quality and efficiency of their supply chains. As the pioneer in the specialty logistics market, ICS has helped bring hundreds of specialty pharmaceutical products to market and served as an integral component in their growth. ICS was founded in 1997 and since then, has organically grown to become the industry leader in outsourced logistics and distribution services for pharmaceutical manufacturers. From strategic program design to enhanced 3PL and performance analytics, ICS goes the extra mile to ensure increased supply chain efficiency, maximum return on investment and enhanced patient care. ICS is the model of excellence in global healthcare logistics.
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.
PharmaLink is a pharmaceutical reverse logistics and disposal provider.
This company is a specialty pharmaceutical company focused on developing innovative drugs.
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
Selkirk is a new aseptic Fill and Finish CMO located in the healthcare hub of the Pacific Northwest, and we are focused on providing the most reliable aseptic fill and finish services available. Our facility is purpose-built for contract manufacturing with unidirectional process flows, electronic batch records and the most advanced SKAN isolators and Bausch and Stroebel filling equipment. At Selkirk we believe that the safety and availability of drug products are the most important priorities for our clients. Selkirk was founded, designed, and built by a team of industry professionals with a passion for creating a newly imagined, first-in-class CMO facility. This group has grown into a multidisciplinary team of Quality and Manufacturing experts with an average of 20 years industry experience.
A global leader in developing and producing responsible packaging for food, beverage, pharma, medical, home- and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content.
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
BioSymetrics is an AI-powered drug discovery company.
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
